Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius
Pharmaceuticals · 22.02.2024 · 17 (3) · 277
DOI: 10.3390/ph17030277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 22.02.2024. Verfasst von Na Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Program of Agricultural Science and Technology (ASTIP) in CAAS, the Key Projects of Alternatives to Antibiotic for Animal Usages of the Agricultural Science and Technology Innovation Program (ASTIP).
Abstract (Originalsprache)
Staphylococcus pseudintermedius (S. pseudintermedius) is the main pathogen causing pyoderma of canines. With the emergence of drug-resistant bacteria, traditional antibiotic treatments are limited. As a potential antibacterial agent, NZ2114 was effective against S. pseudintermedius, including drug-resistant strains. Its bactericidal efficacy was superior to mupiroxacin, ofloxacin and lincomycin. To facilitate the transcutaneous delivery of NZ2114 for the treatment of superficial pyoderma, chemical permeation enhancers were added since water-soluble NZ2114 does not easily penetrate the skin lipid layer. Two different NZ2114 sprays were prepared by combining 1% Azone + 10% propylene glycol (PG) or 5% N-methylpyrrolidone (NMP) + 10% PG with NZ2114 after screening. The cumulative permeability of NZ2114 sprays were 244.149 and 405.245 μg/cm2 at 24 h with an in vitro percutaneous assay of mice skin, which showed a 244% and 405% increase in skin permeability than NZ2114, respectively. In addition, the efficacy of NZ2114 sprays in reducing skin bacteria colonisation was demonstrated in a mouse model of superficial pyoderma (24 mice, 3 mice/group) induced by S. pseudintermedius, and the 5% NMP + 10% PG + NZ2114 group had the best therapeutic effect compared to the other groups. This preparation did not cause any skin irritation, laying the foundation for the development of an effective and non-toxic topical product.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
- Innovative Team of Antimicrobial Peptides and Alternatives to Antibiotics, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
- Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing 100081, China.
- School of Environmental Ecology and Biological Engineering, Wuhan Institute of Technology-WIT, Wuhan 430075, China.
ORCID-Profile: Ruoyu Mao, Jianhua Wang
Förderung
- National Natural Science Foundation of China
- Innovation Program of Agricultural Science and Technology (ASTIP) in CAAS
- the Key Projects of Alternatives to Antibiotic for Animal Usages of the Agricultural Science and Technology Innovation Program (ASTIP)
- the Key Projects of Alternatives to Antibiotic for feed Usages of the Agricultural Science and Technology Innovation Program (ASTIP)
- National Key Research and Development Plan - High Expression of Thiopeptides and their Analogs
- National Key Research and Development Plan—High Expression of Thiopeptides and their Analogs
Zitieren
APA
Yang, N., Huang, Y., Li, Y., Teng, D., Mao, R., Hao, Y., Wei, L., & Wang, J. (2024). Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius. Pharmaceuticals, 17(3), 277. https://doi.org/10.3390/ph17030277
Vancouver
Yang N, Huang Y, Li Y, Teng D, Mao R, Hao Y, et al. Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius. Pharmaceuticals. 2024;17(3):277. doi:10.3390/ph17030277
BibTeX
@article{Yang2024,
author = {Yang, Na and Huang, Yan and Li, Yuanyuan and Teng, Da and Mao, Ruoyu and Hao, Ya and Wei, Lingyun and Wang, Jianhua},
title = {Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {3},
pages = {277},
doi = {10.3390/ph17030277}
}
EUVIMED